Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Clin Microbiol ; 39(10): 3623-32, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11574583

RESUMEN

The molecular fingerprints of 1,349 isolates of Mycobacterium bovis received between 1979 and August 2000 at Agence Française de Sécurité Sanitaire des Aliments (Afssa) have been obtained by spoligotyping. The majority of the isolates (1,266) were obtained from cattle living in France. An apparently high level of heterogeneity was observed between isolates. One hundred sixty-one spoligotypes were observed in total, of which 153 were from French isolates. The two predominant spoligotypes, designated BCG-like and GB54, accounted for 26 and 12% of the isolates, respectively. In addition, 84% of the spoligotypes were found fewer than 10 times. Analysis of the results by clustering and parsimony-based algorithms revealed that the majority of the spoligotypes were closely related. The predominant spoligotype was identical to that of the vaccine strain Mycobacterium bovis BCG, which was isolated in France at the end of the 19th century. Some spoligotypes were closely associated with restricted geographical areas. Interestingly, some spoligotypes, which were frequently observed in France, were also observed in neighboring countries. Conversely, few spoligotypes were common to France and England, and those that were shared were observed at very different frequencies. This last point illustrates the potential role for an international data bank, which could help trace the spread of M. bovis across national borders.


Asunto(s)
Técnicas de Tipificación Bacteriana , Mycobacterium bovis/clasificación , Mycobacterium bovis/genética , Secuencias Repetitivas de Ácidos Nucleicos/genética , Tuberculosis Bovina/epidemiología , Animales , Bovinos , Análisis por Conglomerados , Francia/epidemiología , Mycobacterium bovis/aislamiento & purificación , Oligonucleótidos/análisis , Filogenia , Polimorfismo Genético , Tuberculosis Bovina/microbiología
2.
J Clin Microbiol ; 39(1): 222-7, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11136775

RESUMEN

In order to gain a better understanding of the molecular epidemiology of Mycobacterium bovis isolates in Cameroon, 75 isolates of M. bovis collected in three provinces of northern Cameroon were studied by spoligotyping. For 65 of these isolates, typing was also carried out by pulsed-field gel electrophoresis (PFGE) with DraI, and 18 of the isolates were also typed by restriction fragment length polymorphism (RFLP) analysis with probe IS6110-RHS. Molecular typing of the isolates by these techniques revealed a high degree of homogeneity, with 10 spoligotypes for 75 isolates, four PFGE profiles for 65 isolates, and three RFLP types for 18 isolates. Some types were present in the three different provinces, while some were confined to one or two areas. These results suggest that geographical mapping of M. bovis strains could be helpful for the control of bovine tuberculosis at the regional level. An interesting feature of all the spoligotypes was the absence of spacer 30, suggesting a common origin for all of the Cameroon isolates tested; an evolutionary scenario for the isolates is discussed. In addition, a comparison of the three techniques showed that for M. bovis strain differentiation in Cameroon and in surrounding countries, spoligotyping would be a more discriminating and practical tool for molecular typing than the other two techniques used in this study.


Asunto(s)
Técnicas de Tipificación Bacteriana , Mycobacterium bovis/clasificación , Mycobacterium bovis/genética , Tuberculosis Bovina/microbiología , Animales , Camerún/epidemiología , Bovinos , Elementos Transponibles de ADN/genética , ADN Bacteriano/análisis , ADN Bacteriano/genética , Electroforesis en Gel de Campo Pulsado/métodos , Oligonucleótidos/análisis , Oligonucleótidos/genética , Polimorfismo de Longitud del Fragmento de Restricción , Tuberculosis Bovina/epidemiología
3.
Clin Exp Immunol ; 120(2): 274-9, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10792376

RESUMEN

The 19-kD antigen is a cell wall-associated lipoprotein present in Mycobacterium tuberculosis and in bacille Calmette-Guérin (BCG) vaccine strains. Expression of the 19-kD antigen as a recombinant protein in two saprophytic mycobacteria-M. vaccae and M. smegmatis-resulted in abrogation of their ability to confer protection against M. tuberculosis in a murine challenge model, and in their ability to prime a DTH response to cross-reactive mycobacterial antigens. Induction of an immune response to the 19-kD antigen by an alternative approach of DNA vaccination had no effect on subsequent M. tuberculosis challenge. These results are consistent with a model in which the presence of the 19-kD protein has a detrimental effect on the efficacy of vaccination with live mycobacteria. Targeted inactivation of genes encoding selected antigens represents a potential route towards development of improved vaccine candidates.


Asunto(s)
Antígenos Bacterianos/inmunología , Vacuna BCG/inmunología , Proteínas Bacterianas/inmunología , Tuberculosis/prevención & control , Vacunas de ADN/inmunología , Animales , Antígenos Bacterianos/genética , Vacuna BCG/genética , Proteínas Bacterianas/genética , Modelos Animales de Enfermedad , Ratones , Ratones Endogámicos C57BL , Mycobacterium/inmunología , Mycobacterium smegmatis/inmunología , Mycobacterium tuberculosis/inmunología , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Factores de Tiempo , Tuberculosis/microbiología , Tuberculosis/fisiopatología , Vacunación , Vacunas de ADN/genética
6.
Infect Immun ; 65(5): 1856-62, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9125572

RESUMEN

A 19-kDa lipoprotein from Mycobacterium tuberculosis was expressed as a recombinant antigen in the nonpathogenic mycobacterial host strain M. vaccae. Immunization of mice with the recombinant M. vaccae resulted in induction of a strong type 1 immune response to the 19-kDa antigen, characterized by immunoglobulin G2a (IgG2a) antibodies and gamma interferon (IFN-gamma) production by splenocytes. Immunization with the same antigen in incomplete Freund's adjuvant induced a strong IgG1 response with only low levels of IFN-gamma. Subsequent intravenous and aerosol challenges of immunized mice with virulent M. tuberculosis demonstrated no evidence of protection associated with the response to the 19-kDa antigen; in fact, the presence of the recombinant 19-kDa antigen abrogated the limited protection conferred by M. vaccae (vector control). The recombinant M. vaccae system is a convenient approach to induction of type 1 responses to M. tuberculosis antigens. However, the unexpected reduction in protective efficacy of M. vaccae expressing the 19-kDa antigen highlights the complexity of testing recombinant subunit vaccines and the need for a better understanding of the immune mechanisms required for effective vaccination against tuberculosis.


Asunto(s)
Antígenos Bacterianos/genética , Antígenos Bacterianos/inmunología , Regulación Bacteriana de la Expresión Génica , Hipersensibilidad Inmediata/inmunología , Lipoproteínas/genética , Lipoproteínas/inmunología , Infecciones por Mycobacterium/genética , Infecciones por Mycobacterium/inmunología , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/inmunología , Mycobacterium/genética , Proteínas Recombinantes/inmunología , Tuberculosis Esplénica/genética , Tuberculosis Esplénica/inmunología , Administración Oral , Animales , Anticuerpos Antibacterianos/análisis , Bioensayo , Western Blotting , Susceptibilidad a Enfermedades/inmunología , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Femenino , Adyuvante de Freund/inmunología , Predisposición Genética a la Enfermedad , Inmunización/métodos , Inmunoglobulina G/biosíntesis , Inmunoglobulina G/inmunología , Interferón gamma/biosíntesis , Interferón gamma/inmunología , Ratones , Ratones Endogámicos C57BL , Plásmidos , Recombinación Genética , Bazo/inmunología , Tuberculosis Esplénica/prevención & control , Vacunas Sintéticas/efectos adversos , Vacunas Sintéticas/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA